Orbital Therapeutics

company

About

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease.

  • 11 - 50

Details

Last Funding Type
Seed
Industries
Biotechnology
Founded date
Jan 1, 2022
Number Of Employee
11 - 50
Operating Status
Active

Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Orbital Therapeutics has raised a total of — in funding over 2 rounds. Their latest funding was raised on Sep 7, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 7, 2022 Seed 1 ARCH Venture Partners Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Orbital Therapeutics is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Yes Seed